Given that IBC clearly can develop metastatic disease via hematogenous spread as well as potentially passive spread via the angiolymphatic channels we propose that IBC cells are capable of both E-cadherin positive non-hemotogenous spread as well as more well-described E-cadherin negative promoting invasive behavior. The gene discussed is CDH1; the disease is metastatic neoplasm.